INFU: Gunggunge utang jangka dawa InfuSystem Holdings

Logo grafis InfuSystem (INFU)

The market capitalization trend for InfuSystem Holdings (INFU) demonstrates the 0.02 metric. The company's profit stability is based on long-term partnerships with oncology centers and recurring service payments. The business generates revenue by providing infusion systems and chemotherapy logistics. A dominant position in the outpatient equipment niche and an extensive distribution network reliably protect the company's market share from local players.

INFU InfuSystem: Utang jangka dawa perusahaan ing interval 04.07.2022 - 29.10.2026
Produk seri InfuSystem Inc

InfuSystem Holdings (INFU) is expanding its network of infusion pump rental and service centers, leveraging a recurring payment model. This indicator captures total obligations with maturities exceeding twelve months, reflecting the company's long-term financing strategy. By analyzing the organization's long-term loans and borrowings, one can assess the effectiveness of deleveraging and balance sheet resilience during the post-crisis recovery period. The stability of this metric confirms protection against default, yet signals a potential slowdown in profit growth rates.

Analisis pesaing

Tanggungan utang jangka dawa perusahaan intuitive.com ISRG|Utang jangka dawa perusahaan DHR (Danaher)|BDX - Gunggunge utang jangka dawa|STE (STERIS Corporation) - Utang jangka dawa perusahaan|West Pharma Corp (WST) - Kewajiban jangka dawa perusahaan|BAX (Baxter International) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan MASI|Utang jangka dawa perusahaan Stevanato Group (STVN)|Utang jangka dawa perusahaan Teleflex Inc. TFX|Kewajiban jangka dawa perusahaan Merit Medical Systems Inc|Silihan lan utang jangka dawa perusahaan Nobel Biocare NVST|Utang jangka dawa perusahaan ICUI (ICU Medical, Inc.)|XRAY: Gunggunge utang jangka dawa|Utang jangka dawa perusahaan LeMaitre Vascular|ATRC (AtriCure Inc) - Tanggungan utang jangka dawa perusahaan|STAA: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa niagenbioscience.com (NAGE)|Kewajiban jangka dawa perusahaan ZimVie Inc.|Gedhene kewajiban jangka dawa ANGO (angiodynamics.com)|Utang jangka dawa perusahaan Cerus|TKNO - Silihan lan utang jangka dawa perusahaan|Monogram Technologies Inc - Kewajiban jangka dawa perusahaan|STSS: Utang jangka dawa perusahaan|UTMD (Utah Medical Products) - Utang jangka dawa perusahaan|KORU Medical (KRMD) - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan NYXH (Nyxoah)|Utang jangka dawa MBOT|Utang jangka dawa perusahaan Pro-Dex Corp PDEX|Tanggungan utang jangka dawa perusahaan Zentek Corp ZTEK|Kewajiban jangka dawa perusahaan Elutia Inc. (ELUT)|milestonescientific.com - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan NXGL (NEXGEL)|RVP - Gunggunge utang jangka dawa|Harvard Bioscience, Inc. - Utang jangka dawa perusahaan|FEMY (Femasys Corporation) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan Meihua Medical Technologies (MHUA)|Tanggungan utang jangka dawa perusahaan Predictive Oncology Corp|CJMB - Utang jangka dawa perusahaan|Kewajiban jangka dawa Atrion Corp. ATRI|Kewajiban jangka dawa perusahaan NURO (NeuroMetrix Corp)